Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NAIR study: ISR with or without preoperative chemotherapy for very low-lying rectal cancer
jRCTs031180278Phase 3Completed
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Start
- Feb 2013
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of oxaliplatin + fluorouracil + leucovorin and Capecitabine + oxaliplatin in rectal cancer (2 arms), sponsored by Cancer Institute and Hospital, Chinese Academy of Medical Sciences. Primary endpoint: Relapse-free survival. Started Feb 2013; status: completed.
02
Drugs
oxaliplatin + fluorouracil + leucovorinCapecitabine + oxaliplatin
03
Conditions
rectal cancer
Beyond the preview
Go deeper on jRCTs031180278.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031180278.